John Monroe, PhD is an Emeritus Professor at the Perelman School of Medicine at the University of Pennsylvania. Most recently he led Genentech’s Immunology Discovery Department and was responsible for new target discovery and pre-clinical validation. He also headed the Genentech Immunology Precision Medicine Department and determined precision medicine strategies and early clinical validation of biomarkers for patient selection. He was a tenured Professor at the University of Pennsylvania School of Medicine where for over 20 years he oversaw a research lab and published seminal papers in the field of B lymphocyte biology and immune cell tolerance.
Dr. Monroe received his Ph.D. in Immunology from Duke University studying immune cell receptor signaling and did a post-doctoral fellowship at Harvard Medical School studying T cell modulation of immune responses. He is a former Vice Chair for Research in the Department of Pathology at UPENN and directed their Cancer Immunology Program. He has served on many review committees and editorial boards including as Deputy Editor for Immunological Reviews.